A study was performed to determine the effect of parenteral treatment with four broad-spectrum cephalosporins (cefoperazone, ceftriaxone, ceftazidime, and cefepime) on the number of aerobic gram-negative rods and on the outgrowth of Candida albicans and a multiresistant strain of Citrobacterfreundii in the feces of mice. The estimated fractions of a parenteral dose that were excreted into the gastrointestinal tract were 0.37 for cefoperazone, 0.11 for ceftriaxone, 0.03 for ceftazidime, and 0.002 for cefepime. All four cephalosporins significantly decreased the number of aerobic gram-negative rods in the feces, and virtually all gram-negative rods were eliminated at high doses of cefoperazone, ceftazidime, and ceftriaxone. Furthermore, at high doses these three compounds led to a significant increase of the outgrowth of resistant Citrobacter freundii. The outgrowth of Candida albicans was increased at high doses of cefoperazone and ceftriaxone, whereas ceftazidime and cefepime did not have this effect. The most profound changes in the gastrointestinal ecology were observed during treatment with high doses of cefoperazone. The results suggest that the colonization resistance of the gastrointestinal tract can be substantially decreased by parenteral treatment with cefoperazone and, to a lesser extent, with ceftriaxone and ceftazidime.
Broad-spectrum cephalosporins are frequently used for empirical treatment and for the treatment of gram-negative infections in granulocytopenic patients (15) . These compounds possess a powerful in vitro activity against gramnegative bacteria, including Pseudomonas aeruginosa. Most gram-positive bacteria are also considered susceptible.
Broad-spectrum cephalosporins may also disturb the anaerobic and aerobic intestinal microflora (1, 2, 5) , which can lead to a decrease of colonization resistance to opportunistic pathogens. This may lead subsequently to overgrowth by fungi or multiresistant bacteria, which-especially in granulocytopenic patients-increases the risk of acquiring a nosocomial infection.
The degree of disturbance of the intestinal microflora due to the parenteral administration of antibacterial agents is dependent on the intrinsic activity of the antibacterial agent against the indigenous bacteria of the gastrointestinal tract as well as on the pharmacokinetic characteristics of the antibacterial agent determining the concentration of the agent in the gastrointestinal tract.
In the present study, the effect of parenteral administration of four broad-spectrum cephalosporins (cefoperazone, ceftriaxone, ceftazidime, and cefepime) on the aerobic gramnegative fecal flora and the colonization resistance of the intestinal tract was determined. These four drugs were chosen for several reasons. Cefoperazone was included because it has broad-spectrum activity against intestinal anaerobic bacteria and is excreted predominantly in the bile (6) ; ceftriaxone was included because it is also excreted into the bile (23) , but it lacks broad antianaerobe activity. Ceftazidime was studied because it lacks broad antianaerobe activity and, unlike cefoperazone and ceftriaxone, is mainly excreted by the kidney (22) ; and cefepime was studied because, like ceftazidime, it is mainly excreted by the kidney (9) , but its antibacterial spectrum includes gram-positive * Corresponding author. cocci such as Staphylococcus aureus (13, 14, 25) . Comparison of the effects of these four antibacterial agents was expected to provide information about the relationship among the effect of broad-spectrum cephalosporins on gastrointestinal flora, their in vitro antibacterial spectrum, and their pharmacokinetic characteristics.
MATERIALS AND METHODS
Antibiotics. Cefoperazone (sodium salt, activity 96.4%) was kindly donated by Pfizer Pharmaceuticals, Rotterdam, The Netherlands; ceftazidime (activity 84.2%) was donated by Glaxo, Nieuwegein, The Netherlands; ceftriaxone (activity 83.95%) was donated by Hoffmann-La Roche, Basel, Switzerland; and cefepime (activity 82.6%) was donated by Bristol Myers, Brussels, Belgium. Just before use, solutions of the drugs were prepared freshly in phosphate-buffered saline (PBS), according to the manufacturer's instructions.
Animals. Female specific-pathogen-free Swiss mice (Broekman Institutes, Someren, The Netherlands), aged 5 to 6 weeks, were used throughout the study. The animals were housed in groups of four to five in polycarbonate cages on sterile sawdust and were given acidified tap water and nonsterilized food pellets (type AM-II; Hope Farms, Woerden, The Netherlands) ad libitum. Cages and sawdust were replaced twice weekly. No special measures were taken to prevent coprophagia. The effect of parenteral treatment with once-daily doses of the cephalosporins under study was assessed over 9 to 11 days, the exact duration depending on the conditions of the individual experiments.
Effect of cephalosporins on number of aerobic gram-negative rods in feces of conventional mice. The mice were given one daily subcutaneous injection of the drug under study at various dosages on nine consecutive days. For all experiments, the dose ranges studied were 10 to 160 mg/kg/day for ceftazidime, 6 .25 to 100 mg/kg/day for cefepime, 25 to 400 mg/kg/day for cefoperazone, and 5 to 80 mg/kg/day for ceftriaxone. These experiments used five mice each.
EFFECT OF BROAD-SPECTRUM CEPHALOSPORINS ON GUT FLORA 977 On each weekday, fresh fecal pellets were collected, weighed, and suspended in 1 ml of PBS. Tenfold serial dilutions of these suspensions were made. Samples (0.1 ml) of the dilutions were inoculated on both blood agar plates and MacConkey III agar plates (Oxoid, Basingstoke, United Kingdom) which were incubated at 37°C. After incubation, differential counts were made on the MacConkey agar plates. The lower limit of detection was 500 CFU of aerobic gram-negative rods per g of feces. If no aerobic gramnegative rods were recovered from the feces, the number of CFU per gram of feces was arbitrarily taken as 100 for further calculations. Results are expressed as the geometric mean of the number of aerobic gram-negative rods per gram of feces.
Identification of members of the family Enterobacteriaceae was based on Gram staining, absence of oxidase production, and biotyping by the API 20E system (API Laboratories, La Balme, France).
In addition, the MICs of the cephalosporins for the isolated strains of aerobic gram-negative rods were determined by an agar dilution method (4), with Mueller-Hinton agar (Oxoid) as the test medium and an inoculum density of between 5 x 103 and 5 x 104 CFU per spot.
Effect of cephalosporins on number of Candida albicans in feces of postnatally contaminated mice. The effect of the cephalosporins on the outgrowth of Candida albicans (strain UC-820) was assessed in a murine model of gastrointestinal candidiasis in a separate group of mice, as described by Pope et al. (21) . Six-day-old mice were orally contaminated with 2 x 106 to 5 x 106 CFU of Candida albicans. At the age of 21 to 22 days, the mice were weaned and housed in groups of four. Each treatment group consisted of eight mice. Treatment with the cephalosporins was started on day 1 after weaning and consisted of a single subcutaneous dose of the drug per day. Control mice received PBS. Fresh feces were collected before and various days after the start of treatment. These samples were weighed, suspended, and diluted in PBS, after which the number of Candida albicans per gram of feces was determined by quantitative culturing on Sabouraud agar (Oxoid) supplemented with 20 mg of kanamycin (Gist-Brocades, Delft, The Netherlands) per liter and BIGGY (bismuth sulfite glucose glycine yeast) agar (Oxoid). Plates were incubated at 37°C for 48 h, and the CFU were counted. The lower limit of detection of this assay was 500 CFU of Candida albicans per g of feces.
Oral contamination with Citrobacter freundii and effect of cephalosporins on recovery of this microorganism from feces of mice. The effect of each of the cephalosporins on the outgrowth of a resistant strain of Citrobacterfreundii (MIC: ceftazidime, 128 ,ug/ml; ceftriaxone, 64 ,ug/ml; cefoperazone, 64 ,ug/ml; and cefepime, 0.25 ,ug/ml) was assessed after daily oral administration of an inoculum of 5 x 107 CFU of Citrobacter freundii through a feeding needle for 7 days. This strain of Citrobacter freundii, chosen from a panel of clinical isolates of gram-negative bacteria resistant to broadspectrum cephalosporins ( Effect of cephalosporins on relative cecal weight and total number of bacteria in the cecum. The relative cecal weight (16) and the total number of bacteria per gram of cecum were determined after 10 days of parenteral treatment with a cephalosporin. For these determinations, mice were killed by cervical dislocation, the cecum was removed and weighed, and the total wet weight was expressed as milligrams per gram of body weight. For the total count of bacteria per gram of cecal homogenate, the excised cecum was homogenized in 2 ml of sterile ice-cold PBS, the homogenate was diluted in PBS, and the total number of bacteria in the appropriate dilutions was determined on Gram-stained slides and compared with an external standard by the method of Holdeman and Moore (11) . This count reflects the number of anaerobic bacteria in the cecum (12, 17) .
Pharmacokinetics of cephalosporins in cecal contents of mice. Single-dose pharmacokinetic studies were performed for the following subcutaneous doses: cefoperazone, 100 mg/kg; ceftazidime, 160 mg/kg; ceftriaxone, 5 mg/kg; and cefepime, 100 mg/kg. At various time points after administration, mice were killed by exposure to 100% C02, the cecum was excised, and the cecal contents were removed, weighed, and diluted in 2 ml of PBS. This material was centrifuged at 1,500 x g for 10 min at room temperature, after which the concentrations in the supernatant were determined by high-performance liquid chromatography (HPLC). The area under the concentration-time curve (AUC) was calculated according to the trapezoidal rule.
HPLC analysis of cephalosporin concentrations. Acetonitrile, dichloromethane, and sodium acetate were of analytical grade and were supplied by Merck (Darmstadt, Federal Republic of Germany). The liquid chromatographic system consisted of a constant-flow pump (model 1000; Sykam, Analytica BV, Rijswijk, The Netherlands), a Rheodyne model 7125 injection valve equipped with a 20-,lI sample loop (Chrompack, Middelburg, The Netherlands), a stainless-steel column (length, 10 cm, and internal diameter, 3 mm), and a Spectroflow 773 absorbance detector (Kipp & Zn., Delft, The Netherlands). For monitoring, the detector was set at 254 nm for ceftazidime, 274 nm for ceftriaxone, 254 nm for cefoperazone, and 280 nm for cefepime. The column was home-packed with 5-,um Hypersil ODS (Shandon SPL, Cheshire, United Kingdom) according to a pressurized-slurry technique.
The extraction procedure applied to the samples containing cefoperazone, ceftazidime, or ceftriaxone was as follows. A 500-,ul aliquot of the sample was vigorously mixed with an equal volume of acetonitrile in a polypropylene tube on a whirlmixer for 30 s. After centrifugation for 5 min at 1,200 x g, 400 RI of the supernatant was mixed with 3 ml of dichloromethane for 30 s and centrifuged for 5 min at 1,200 x g. A 20-pu aliquot of the upper aqueous phase containing the analyte was injected onto the column and chromatographed at a flow rate of 1 ml/min with a mobile phase consisting of 0.7% (vol/vol) acetonitrile in a 0.005-mol/liter 3 ). In week 2 of the experiment, the oral contamination was LTS discontinued and the number of CFU of Citrobacterfreundii tended to fall to levels below the detection limit (500 CFU/g umber of aerobic gram-negaof feces). For statistical purposes, these mice were arbitraral mice. The effect of 9 to 10 ily considered to have 100 CFU of Citrobacterfreundii per g daily subcutaneous dose of in their feces (Fig. 3) . triaxone, or cefepime on the In cephalosporin-treated mice, the administration of the negative rods in the feces is drug and oral contamination with Citrobacter freundii were osporins reduced the number begun simultaneously. Treatment with 400 mg of cefoperan the feces, but cefepime was zone per kg per day had the strongest effect on the microbial n cefoperazone, ceftazidime, ecology of the intestinal tract, resulting in an increase of the CFU/g of feces (Fig. 3) . Cefoperazone at lower dosages, 40 mg or more of ceftazidime per kg, or 20 mg or more of ceftriaxone per kg daily had less pronotunced effects on the numbers of Citrobacter freundii in the feces, which increased to between 106 and 108 CFU/g of feces. Treatment with cefepime (up to 100 mg/kg/day) did not have any significant effect on the recovery of this strain (Fig. 3 ), but this strain was susceptible to cefepime (MIC, 0.25 ,ug/ml).
Effect of cephalosporins on relative cecal weight and total number of bacteria in the cecum. The relative cecal weight is another parameter of colonization resistance, and the total number of bacteria in the cecum reflects the number of anaerobes in that organ. Administration of 400 mg of cefoperazone per kg per day or 20 or 80 mg of ceftriaxone per kg per day led to a significant increase in the relative cecal weight (Table 2 ). Qnly 400 mg of cefoperazone per kg per day gave a significant decrease in the total number of bacteria in the cecum (Table 2 ). Other treatments had no effect on either the relative cecal weight or the total number of bacteria in the cecum.
Pharmacokinetics of cephalosporins in cecal contents in mice. The concentrations of the cephalosporins in the contents of the cecum are shown in Fig. 4 To estimate the percentage of a parenteral dose excreted into the gastrointestinal tract, we also measured concentrations of ceftazidime in cecal contents after oral administration. The AUC from 0 to 5 h (AUCO-5) for cecal contents after an oral dose of 160 mg of ceftazidime per kg was 19, 420 p,g. h/g. If it is correct to assume that orally administered ceftazidime is not absorbed or metabolized in the gastroin- testinal tract of mice, this value can be us fraction of the subcutaneous (s.c.) dose excreted into the gastrointestinal tract, following equation: F = AUCS.C./AUCOra excreted fraction. For a subcutaneous d ceftazidime per ml, this value was 0.03, i 3% of a subcutaneously administered dose excreted into the gastrointestinal tract. U for the other three drugs, we calculated the dose excreted into the gastrointestinal 36.5% for cefoperazone, 11.1% for ceftriz for cefepime. These percentages should be estimates of the true percentage of the dos into the gastrointestinal tract of mice.
DISCUSSION
The results of the present study showt administration of broad-spectrum cephalos major ecological impact on the intestinal fli the investigated drugs (cefoperazone, cefta and ceftriaxone) caused a marked dose-de of the number of aerobic gram-negative argued that this decrease might even be m( would have been prevented. However, th that the effects of the various dosage i comparable, because the mice were alh closed system under identical conditions. coprophagic behavior of mice has to be bc results in mice are to be extrapolated to the Other ecological effects of parenteral ti cephalosporins were observed as well. In dose: 160 mg/kg s.c. taminated with a resistant strain of Citrobacterfreundii, the number of these organisms in the feces increased during parenteral administration of cefoperazone, ceftazidime, and * * ceftriaxone but not during administration of cefepime. It is & . noteworthy that this outgrowth of Citrobacter freundii occurred despite the fact that the concentrations of the cephalosporins in the cecal contents were much higher than the * MIC. For example, the outgrowth of the Citrobacter strain & in the feces increased with the dose of cefoperazone up to 400 mg/kg/day. At this dose of cefoperazone, the concentrations in cecal contents can be expected to be as high as 2 3 4 5 hours 40,000 pg/g, whereas the MIC of cefoperazone for this strain was only 64 ,ug/ml. Therefore, this strain of Citrobacter freundii can be considered resistant in vivo (except for cefepime), and therefore it is a suitable indicator strain for mice with a disturbed intestinal microflora (17) and has been shown to correlate with a decrease in colonization resistance of the gastrointestinal tract (16) .
Colonization resistance of the gastrointestinal tract has 1 2 3 4 5 hours classically been linked to an intact anaerobic microflora (26) . Until now, the question of which anaerobic bacteria are nts of mice given a important in maintaining colonization resistance and e, ceftazidime, cef-whether aerobic bacteria can play a role in this process as the measured value well is unsolved. The main problem in addressing these questions is the culturing and identification of murine intestinal anaerobes. Despite laborious anaerobic culture methods, no one has yet succeeded in culturing more than 60 to ed to estimate the 80% of the anaerobic intestinal bacteria of mice (12, 18) . In of a drug that iS the present study, we decided to count the anaerobic bacteaccording to the ria indirectly via a microscopical method (11, 17) . Since , where F iS the anaerobic bacteria account for more than 90% of the flora of ose of 160 mg of the mouse cecum (19) , the decrease in the total number of which means that bacteria implies a decrease in the number of anaerobic -of ceftazidime IS bacteria in the cecum.
rsing this estimate
Various parameters of disturbed colonization resistance in proportion ofthe mice treated with broad-spectrum cephalosporins can be tract, which was compared on the basis of the present results. A standard axone, and 0.16% method used to establish a decrease of colonization resisconsidered rough tance is measurement of the outgrowth of a resistant aerobic se that is excreted gram-negative rod in the feces of mice during treatment with antimicrobial agents. In this study, Citrobacterfreundii was used as the test strain because it combines two characteristics: low sensitivity to three of the four cephalosporins under study and adequate recovery from the feces of mice. Inzd that parenteral creased outgrowth of Citrobacter freundii in the feces ocsporins can have a curred at low doses of ceftazidime and cefoperazone, lora of mice, since whereas at these dosages all other parameters of decreased zidime, cefepime, colonization resistance, i.e., outgrowth of Candida albicans pendent decrease in feces, relative cecal weight, and total number of bacteria rods. It may be in the cecum, showed no deviation from the controls (Table  ore if coprophagia 3). This led us to conclude that the latter three parameters lis does not mean are less sensitive for the detection of reduced colonization regimens are not resistance than the outgrowth of Citrobacterfreundii in the vays housed in a feces of mice treated with broad-spectrum cephalosporins is. Nevertheless, the The ecological changes of the intestinal flora of mice by rne in mind if the parenteral treatment with cephalosporins described in the -human situation.
present study can also be expected to occur in humans. The reatment with the concentrations of cefoperazone in the feces of a group of mice orally confour patients treated with 4 g of cefoperazone per day varied 980 VAN OGTROP ET AL. (2) measured biliary excretion of ceftriaxone during the steady state in five healthy male volunteers. They estimated that 11 to 65% of the parenteral dose of ceftriaxone was excreted into the biliary tract. In these individuals, ceftriaxone concentrations were measured in the feces 1 day after they had received a total dose of approximately 500 mg of ceftriaxone. In two of these subjects, no ceftriaxone concentrations could be detected in the feces, whereas in the other three subjects, the ceftriaxone concentrations ranged from 28 to 75 ,ug/g. To our knowledge, there is no information on the concentrations of ceftazidime and cefepime in the feces of humans, but concentrations of these two drugs in the feces can be expected to be much lower than those of cefoperazone and ceftriaxone, because these antibiotics are mainly renally cleared.
The present study on the effects of cephalosporins on the gastrointestinal ecology in mice shows some similarities with those in humans. For example, Giuliano et al. (10) found that treatment of healthy volunteers with cefoperazone led to a dramatic increase in the number of yeasts in the feces, whereas treatment with cefoxitin had much less effect. The antibacterial spectra of the two drugs are similar, but the concentrations of cefoxitin in the feces were much lower than those of cefoperazone.
That the colonization resistance-disturbing potential of antibiotics is clinically relevant has never been proved conclusively, but a decrease of colonization resistance is believed to increase the chance of overgrowth of the gastrointestinal tract by multiresistant bacteria or yeasts. In patients with increased susceptibility to infection, intestinal overgrowth with potentially pathogenic microorganisms increases the chance of an infection with those organisms, especially if the mucosa of the gastrointestinal tract has been damaged by cytostatic agents or irradiation. This situation underscores the importance of knowing the therapeutic efficacy as well as the colonization resistance-disturbing effect of a given antibiotic. A study on both these effects could be expected to yield an indication of the relationship between the dosage at which colonization resistance is decreased and the dosage giving maximum therapeutic efficacy. In vitro cefepime and ceftriaxone have much lower MICs against members of the family Enterobacteriaceae than ceftazidime and cefoperazone (8, 13, 25) . We have observed that the in vitro order of potency of these four cephalosporins is similar to the in vivo order of potency in an experimental thigh muscle infection with E. coli in irradiated mice (27) , indicating that in therapeutic doses cefepime and ceftriaxone have less effect on colonization resistance than ceftazidime and cefoperazone. Although direct extrapolation to humans should be done cautiously, our results suggest that the margin of safety with respect to colonization resistance is greater for cefepime and ceftriaxone than for ceftazidime and cefoperazone.
